Hycells’s 2025 Annual Celebration Concludes Successfully | Reflecting on the Past, Ushering in a New Beginning
Release Date:
2025-01-21 14:54
Summarize the past, usher in a new beginning.
On January 17, 2025, the 2025 Heyou Annual Gala, themed “Reflecting on the Past, Ushering in a New Beginning,” was held as scheduled.
At the outset of the annual meeting, representatives from Operations, Marketing, Clinical Affairs, Manufacturing, and Technology each delivered summary reports, providing a detailed overview of future strategic plans that encompassed areas such as technological innovation, market expansion, and talent development. In addition, the reports used data and visual aids to comprehensively present the company’s overall operational performance and achievements for 2024. The presentations candidly analyzed the factors behind the successes while also identifying current challenges and areas for improvement.
The figure shows the summary reports submitted by the heads of various departments.
At the conclusion of the meeting, Mr. Zhou Bin, General Manager of Hycells, delivered the closing remarks. He began by extending his sincerest gratitude to all colleagues, emphasizing that every step of Hycells’s growth and transformation has been made possible only through your tireless efforts and unwavering commitment. “Summing up the past” is an affirmation of our hard work and dedication, while “a fresh start” embodies our aspirations and solemn commitment to the journey ahead. 2024 has been a particularly challenging year—both for the industry as a whole and for each of us individually. Thanks to the relentless efforts of all our colleagues in overcoming obstacles and pressing forward, Hycells has successfully undergone a remarkable transformation. We look forward to maintaining our spirit of unity, collaboration, and bold innovation as we strive to embark on the next exciting chapter of our journey.
Through diligent and unremitting efforts, rewards have been reaped as expected. Hycells recognized and presented cash awards to individuals and teams that made outstanding contributions this year.
The photo shows the awards ceremony for individuals and teams at the annual conference.
Annual Meeting Performance
The annual highlight of the year-end gala is here! Once again, the self-written and self-performed cultural and entertainment acts by our colleagues have stolen the spotlight.
The Operations Department delivered an irresistibly adorable “Four Little Swans” dance; though the costumes and props were a bit ill-fitting, this very imperfection only made the four endearingly clumsy swans’ performance all the more natural and authentic. The Marketing Department wowed the entire audience with a free-spirited runway show and medley of songs, truly stealing the spotlight. The Clinical Department’s skit, “You’ve Got It, So Do I,” featured three overly affected office ladies colliding with three authentically spirited girls in traditional ethnic style, sparking a series of hilariously absurd comparisons—and creating a magical chemistry in the process. Meanwhile, the Technical Department completely broke from their usual serious and meticulous image with a breathtaking dragon-dancing finale. Dragon dancing is a quintessential element of Chinese traditional culture, imbued with profound ceremonial significance and brimming with heartfelt blessings: may every team member enjoy good fortune and auspiciousness in the Year of the Snake, with blessings that last forever!
Between performances, several rounds of interactive games and prize draws were held. With a wide array of exciting prizes, every participant went home with a gift—truly a thoughtful gesture from Hycells to all the little friends!
“Summing Up the Past, Ushering in a New Beginning” is not only the theme of this annual conference—it is also the shared aspiration and guiding principle for every member of Hycells. Let us carry forward the gains and lessons of the past, approach our journey with unwavering passion and courage, and together set out to conquer new horizons!
The photo shows a group shot of all the colleagues at Hycells.
Please click for the highlight video of the annual meeting. ：
Related News
(II) Security Assurance Section | Safety First, Defense Prioritized
Compliance‑driven traceability establishes a clear “identity” for the product, but the real test lies in safety. While a multi‑donor pooling strategy ensures batch‑to‑batch consistency, it also inevitably elevates the risk of pathogen introduction. In the face of these associated risks and challenges, Heyousheng has never compromised on its manufacturing standards—relying on more precise design to deliver on its promise of enhanced safety.
This article will examine how He Yousheng proactively integrates the quality management system into the hospital setting, translating compliance requirements into concrete, actionable practices starting at the sample collection stage, thereby establishing a trust‑based chain that can withstand audit scrutiny.
In selecting hPL raw materials, Heyousheng consistently upholds the principle that “safety is determined at the source.” The samples used in production are rigorously collected in accordance with applicable standards and undergo stringent donor screening, effectively mitigating the risk of disease transmission at the very outset. Moreover, from informed consent forms and ethical approvals to clinical‑grade collection under the GCP framework, Heyousheng has established a fully traceable documentation chain, ensuring that every sample is accounted for and verifiable. In contrast to the industry’s longstanding reliance on the conventional model of using expired blood supplies from blood banks, this approach represents a structural, generational upgrade.
Recently, the research team led by Researcher Bian Yingjie at the Guangzhou National Laboratory, in collaboration with partners from Sun Yat-sen University, published a study titled “Iron overload in the tumor microenvironment induces CD8⁺ T cell ferroptosis and dysfunction” in the internationally renowned academic journal Nature Communications.
Hycells Recruitment | Never Stop Exploring, Never Stop Innovating
The company consistently upholds its core values of “people‑centricity, quality first, and innovation as the foundation,” remains driven by technological innovation, and sets new industry benchmarks for domestic innovation, thereby laying a solid foundation for the development and global advancement of China’s innovative pharmaceutical sector.
The HiXpan® NK Serum-Free Culture Kit, Version 3.0, is manufactured in strict compliance with GMP standards, and its production system fully adheres to relevant guidelines and regulations, including the “818 Requirements,” positioning it for pharmaceutical‑grade manufacturing and applications.
Contact Us
Phone: 021-36696819
Mobile phone:13061948224(Ms. Yu)
Email:monika@hys-bio.com
Wuxi Headquarters: 4th Floor, No. 15-1, Xianfeng Middle Road, Anzhen Subdistrict, Xishan District, Wuxi City
Shanghai Branch: Room 503, Building 2, No. 999 Jiangyue Road, Minhang District, Shanghai
Official Website
WeChat Official Account
Message Board